Angiotensin II type 1 receptor agonistic autoantibody blockade improves postpartum hypertension and cardiac mitochondrial function in rat model of preeclampsia
Open Access
- 2 November 2021
- journal article
- research article
- Published by Springer Nature in Biology of Sex Differences
- Vol. 12 (1) , 1-12
Abstract
Women with preeclampsia (PE) have a greater risk of developing hypertension, cardiovascular disease (CVD), and renal disease later in life. Angiotensin II type I receptor agonistic autoantibodies (AT1-AAs) are elevated in women with PE during pregnancy and up to 2-year postpartum (PP), and in the reduced uterine perfusion pressure (RUPP) rat model of PE. Blockade of AT1-AA with a specific 7 amino acid peptide binding sequence (‘n7AAc’) improves pathophysiology observed in RUPP rats; however, the long-term effects of AT1-AA inhibition in PP is unknown. Pregnant Sprague Dawley rats were divided into three groups: normal pregnant (NP) (n = 16), RUPP (n = 15), and RUPP + ‘n7AAc’ (n = 16). Gestational day 14, RUPP surgery was performed and ‘n7AAc’ (144 μg/day) administered via osmotic minipump. At 10-week PP, mean arterial pressure (MAP), renal glomerular filtration rate (GFR) and cardiac functions, and cardiac mitochondria function were assessed. MAP was elevated PP in RUPP vs. NP (126 ± 4 vs. 116 ± 3 mmHg, p < 0.05), but was normalized in in RUPP + ‘n7AAc’ (109 ± 3 mmHg) vs. RUPP (p < 0.05). PP heart size was reduced by RUPP + ’n7AAc’ vs. RUPP rats (p < 0.05). Complex IV protein abundance and enzymatic activity, along with glutamate/malate-driven respiration (complexes I, III, and IV), were reduced in the heart of RUPP vs. NP rats which was prevented with ‘n7AAc’. AT1-AA inhibition during pregnancy not only improves blood pressure and pathophysiology of PE in rats during pregnancy, but also long-term changes in blood pressure, cardiac hypertrophy, and cardiac mitochondrial function PP.Keywords
All Related Versions
Funding Information
- American Heart Association (18CDA34110264)
This publication has 76 references indexed in Scilit:
- Comparative Proteomics Analysis Suggests that Placental Mitochondria are Involved in the Development of Pre-EclampsiaPLOS ONE, 2013
- Agonistic Autoantibodies to the Angiotensin II Type I Receptor Cause Pathophysiologic Characteristics of PreeclampsiaGender Medicine, 2012
- Receptor-activating autoantibodies and disease: preeclampsia and beyondExpert Review of Clinical Immunology, 2011
- Angiotensin II Type 1 Autoantibody Induced Hypertension During Pregnancy Is Associated With Renal Endothelial DysfunctionGender Medicine, 2011
- Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsiaCurrent Opinion in Pharmacology, 2011
- Hypertension in Response to Autoantibodies to the Angiotensin II Type I Receptor (AT1-AA) in Pregnant RatsHypertension, 2009
- How mitochondria produce reactive oxygen speciesBiochemical Journal, 2008
- Autoantibodies to the Angiotensin Type I Receptor in Response to Placental Ischemia and Tumor Necrosis Factor α in Pregnant RatsHypertension, 2008
- Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant miceNature Medicine, 2008
- Persistent abnormalities in plasma volume and renal hemodynamics in patients with a history of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1998